222 related articles for article (PubMed ID: 15258415)
1. Levels of human tissue kallikrein in the vitreous fluid of patients with severe proliferative diabetic retinopathy.
Pinna A; Emanueli C; Dore S; Salvo M; Madeddu P; Carta F
Ophthalmologica; 2004; 218(4):260-3. PubMed ID: 15258415
[TBL] [Abstract][Full Text] [Related]
2. Vitreous vascular endothelial growth factor concentrations in proliferative diabetic retinopathy versus proliferative vitreoretinopathy.
Citirik M; Kabatas EU; Batman C; Akin KO; Kabatas N
Ophthalmic Res; 2012; 47(1):7-12. PubMed ID: 21691136
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of RAGE and its ligands in proliferative retinal disease.
Pachydaki SI; Tari SR; Lee SE; Ma W; Tseng JJ; Sosunov AA; Cataldergirmen G; Scarmeas N; Caspersen C; Chang S; Schiff WM; Schmidt AM; Barile GR
Exp Eye Res; 2006 May; 82(5):807-15. PubMed ID: 16364297
[TBL] [Abstract][Full Text] [Related]
4. Persistent secretion of vascular endothelial growth factor into the vitreous cavity in proliferative diabetic retinopathy after vitrectomy.
Itakura H; Kishi S; Kotajima N; Murakami M
Ophthalmology; 2004 Oct; 111(10):1880-4. PubMed ID: 15465550
[TBL] [Abstract][Full Text] [Related]
5. Vitreous levels of angiopoietin 2 and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.
Watanabe D; Suzuma K; Suzuma I; Ohashi H; Ojima T; Kurimoto M; Murakami T; Kimura T; Takagi H
Am J Ophthalmol; 2005 Mar; 139(3):476-81. PubMed ID: 15767056
[TBL] [Abstract][Full Text] [Related]
6. Soluble TNF receptors in vitreoretinal proliferative disease.
Limb GA; Hollifield RD; Webster L; Charteris DG; Chignell AH
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1586-91. PubMed ID: 11381065
[TBL] [Abstract][Full Text] [Related]
7. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.
Limb GA; Hickman-Casey J; Hollifield RD; Chignell AH
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2453-7. PubMed ID: 10476819
[TBL] [Abstract][Full Text] [Related]
8. Vitreous levels of reactive oxygen species in proliferative diabetic retinopathy.
Yeh PT; Yang CM; Huang JS; Chien CT; Yang CH; Chiang YH; Shih YF
Ophthalmology; 2008 Apr; 115(4):734-737.e1. PubMed ID: 18177940
[TBL] [Abstract][Full Text] [Related]
9. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
Matsunaga N; Chikaraishi Y; Izuta H; Ogata N; Shimazawa M; Matsumura M; Hara H
Ophthalmology; 2008 Nov; 115(11):1916-22. PubMed ID: 18718666
[TBL] [Abstract][Full Text] [Related]
10. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
11. Role of intravitreal inflammatory cytokines and angiogenic factors in proliferative diabetic retinopathy.
Zhou J; Wang S; Xia X
Curr Eye Res; 2012 May; 37(5):416-20. PubMed ID: 22409294
[TBL] [Abstract][Full Text] [Related]
12. Elevated vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy.
Deng J; Wu DZ; Gao R
Yan Ke Xue Bao; 1999 Mar; 15(1):17-21. PubMed ID: 12579655
[TBL] [Abstract][Full Text] [Related]
13. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic shift in vitreous after vitrectomy in patients with proliferative diabetic retinopathy.
Yoshida S; Nakama T; Ishikawa K; Arima M; Tachibana T; Nakao S; Sassa Y; Yasuda M; Enaida H; Oshima Y; Kono T; Ishibashi T
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6997-7003. PubMed ID: 22977138
[TBL] [Abstract][Full Text] [Related]
15. C-C chemokines in the vitreous of patients with proliferative vitreoretinopathy and proliferative diabetic retinopathy.
Capeans C; De Rojas MV; Lojo S; Salorio MS
Retina; 1998; 18(6):546-50. PubMed ID: 9869464
[TBL] [Abstract][Full Text] [Related]
16. Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase.
Coral K; Angayarkanni N; Gomathy N; Bharathselvi M; Pukhraj R; Rupak R
Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3607-12. PubMed ID: 19369240
[TBL] [Abstract][Full Text] [Related]
17. Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy.
Wang X; Wang G; Wang Y
Am J Ophthalmol; 2009 Dec; 148(6):883-9. PubMed ID: 19837381
[TBL] [Abstract][Full Text] [Related]
18. Levels of pentosidine in the vitreous of eyes with proliferative diabetic retinopathy, proliferative vitreoretinopathy and retinal detachment.
Tomé CC; De Rojas Silva MV; Rodríguez-García J; Rodríguez-Segade S; Sánchez-Salorio M
Graefes Arch Clin Exp Ophthalmol; 2005 Dec; 243(12):1272-6. PubMed ID: 15947940
[TBL] [Abstract][Full Text] [Related]
19. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
20. Correlation between ficolin-3 and vascular endothelial growth factor-to-pigment epithelium-derived factor ratio in the vitreous of eyes with proliferative diabetic retinopathy.
Zheng B; Li T; Chen H; Xu X; Zheng Z
Am J Ophthalmol; 2011 Dec; 152(6):1039-43. PubMed ID: 21851923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
